The ARRE Foundation strategically funds research that paves the way for targeted treatments and high-quality, standardized care. Our three key areas of investment include:
- Clinical research: We fund studies that define how ASXL-related disorders appear and progress over time – critical groundwork for designing clinical trials and developing future care guidelines.
- Basic and translational science: We support research that explores the underlying biology of ASXL genes to uncover therapeutic targets and inform the development of disease-modifying treatments.
- Research infrastructure and capacity: We invest in tools, networks, and data resources that expand the global ASXL research community and accelerate collaborative progress.
